BTIG raised the firm’s price target on Upwork (UPWK) to $18 from $16 and keeps a Buy rating on the shares as part of a broader research note ...

Fintel reports that on December 2, 2024, BTIG initiated coverage of BrightView Holdings (NYSE:BV) with a Buy recommendation.

BTIG downgraded AnaptysBio (ANAB) to Neutral from Buy without a price target The company’s topline data from the Phase 2b trial of ANB032 in ...

Fintel reports that on December 2, 2024, BTIG downgraded their outlook for AnaptysBio (NasdaqGS:ANAB) from Buy to Neutral.

On Friday, Synchrony Financial (SYF) stock saw a modest uptick, ending the day at $67.6 which represents a slight increase of $0.38 or 0.57% from the prior close of $67.22. The stock opened at $68.04 ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 7.01% of ...

Outlook Therapeutics (NASDAQ:OTLK – Free Report) had its target price reduced by BTIG Research from $50.00 to $9.00 in a ...

Zscaler (NASDAQ:ZS – Get Free Report) had its price objective upped by research analysts at BTIG Research from $205.00 to ...

Tech was leading the way lower for stocks Wednesday. BTIG Chief Market Technician Jonathan Krinsky noted that while tech ...

Embecta (EMBC) stock gains as BTIG upgrades the stock citing an end to its patch pump program announced with its Q4 FY24 ...

BTIG upgraded Aclaris Therapeutics (ACRS) to Buy from Neutral with an $8 price target In a “transformative transaction,” Aclaris has acquired full ex-China rights to an anti-TSLP humanized mAb ...

NEW YORK--(BUSINESS WIRE)--BTIG announced today that its Digital Health Forum will take place on Monday, November 25, 2024. The event will be hosted by David Larsen, CFA, BTIG Healthcare IT and ...